Valcyte (valganciclovir)

Valcyte works by preventing the spread of cytomegalovirus (CMV) disease, or slowing the growth of CMV. It is indicated for the treatment of CMV retinitis in adult patients with acquired immunodeficiency syndrome (AIDS), and the prevention of CMV disease in adult and paediatric solid organ transplant patients who are at risk of infection.

M-PK-00001196

Solutions
Pharma Products
See all Pharma Products

This information is intended for HCP only. This is a prescription based drug. Please consult your doctor if you need more information.

please be aware that you are leaving this website.